Acne Vulgaris
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with uncontrolled steatorrhea and vomiting will not be included in the study. In addition to those who are taking anti-inflammatory drugs (non-steroids - ANES and corticosteroids), antibiotics or those with serious diseases, kidney, liver, etc.
Exclusion criteria
Exclusion criteria: Patients who discontinue supplements for 7 consecutive days and who fail to follow any guidelines given for the study will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of acne lesions on the face, with reduction in the number of characteristic lesions: comedones, papules and pustules. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of nutritional, biochemical-inflammatory and metabolic profile. Reduction of fat percentage, body mass index, insulin resistance, with reduction of the glucose to insulin ratio, by HOMA-IR; reduction of blood concentration of free testosterone, C-reactive protein, subjective evaluation, tumor necrosis factor, fructosamine. Increased blood concentration of serum zinc and magnesium. | — |
Countries
Brazil
Contacts
Universidade Federal do Rio de Janeiro